UnitedHealth

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade UnitedHealth 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About UNH

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. 

CEO
Stephen J. Hemsley
CEOStephen J. Hemsley
Employees
390,000
Employees390,000
Headquarters
Eden Prairie, Minnesota
HeadquartersEden Prairie, Minnesota
Founded
1977
Founded1977
Employees
390,000
Employees390,000

UNH Key Statistics

Market cap
388.85B
Market cap388.85B
Price-Earnings ratio
31.57
Price-Earnings ratio31.57
Dividend yield
2.14%
Dividend yield2.14%
Average volume
6.22M
Average volume6.22M
High today
$428.60
High today$428.60
Low today
$419.03
Low today$419.03
Open price
$424.00
Open price$424.00
Volume
5.80M
Volume5.80M
52 Week high
$430.20
52 Week high$430.20
52 Week low
$234.60
52 Week low$234.60

Stock Snapshot

UnitedHealth(UNH) stock is priced at $428.00, giving the company a market capitalization of 388.85B. It carries a P/E multiple of 31.57 and pays a dividend yield of 2.14%.

As of 2026-07-08, UnitedHealth(UNH) stock has fluctuated between $419.03 and $428.60. The current price stands at $428.00, placing the stock +2.1% above today's low and -0.1% off the high.

The UnitedHealth(UNH)'s current trading volume is 5.8M, compared to an average daily volume of 6.22M.

In the last year, UnitedHealth(UNH) shares hit a 52-week high of $430.20 and a 52-week low of $234.60.

In the last year, UnitedHealth(UNH) shares hit a 52-week high of $430.20 and a 52-week low of $234.60.

UNH News

Nasdaq 7h
This Stock Stumbled Last Year. Now It's the First Half's Best Performing Mega-Cap Healthcare Stock. Is It Too Late to Buy?

Key Points UnitedHealth faced several challenges last year, but it has taken important steps to address problem areas. The stock climbed 25% in the first half...

This Stock Stumbled Last Year. Now It's the First Half's Best Performing Mega-Cap Healthcare Stock. Is It Too Late to Buy?
TipRanks 19h
UnitedHealth Stock Wins a Price Target Boost ahead of Earnings

UnitedHealth (UNH) is scheduled to release its second-quarter fiscal 2026 results on July 16. Ahead of the earnings release, HSBC analyst Sidharth Sahoo raised...

Simply Wall St 22h
How Investors May Respond To UnitedHealth Group Covering Guardant’s Shield Blood Test For Colon Cancer

In recent days, Guardant Health announced that its Shield blood test for colorectal cancer screening is now covered for eligible UnitedHealth Group members aged...

How Investors May Respond To UnitedHealth Group Covering Guardant’s Shield Blood Test For Colon Cancer

Analyst ratings

77%

of 30 ratings
Buy
76.7%
Hold
20%
Sell
3.3%

More UNH News

TipRanks 2d
UnitedHealth price target raised to $380 from $300 at HSBC

HSBC analyst Sidharth Sahoo raised the firm’s price target on UnitedHealth (UNH) to $380 from $300 and keeps a Hold rating on the shares. In a sector note on He...

Nasdaq 2d
CVS Health vs. UnitedHealth: Comparing Revenue Trends for These Healthcare Companies

Key Points UnitedHealth generates higher overall revenue, though CVS Health has occasionally narrowed the gap between the two companies. Both companies experi...

CVS Health vs. UnitedHealth: Comparing Revenue Trends for These Healthcare Companies
Simply Wall St 3d
UnitedHealth Group Stock Looks Reasonable On Earnings Yet Stretched On Broader Checks

UnitedHealth Group stock has climbed 41.5% over the past year, yet its valuation checks paint a more mixed picture, with some indicators suggesting the shares m...

UnitedHealth Group Stock Looks Reasonable On Earnings Yet Stretched On Broader Checks
Benzinga 3d
UNH, Humana, CVS Soar, and Wall Street Analysts Take Note

UNH, CVS, and HUM stocks chart | Source: TradingView The rally is a major reversal considering that these companies have been some of the top laggards in Wall S...

UNH, Humana, CVS Soar, and Wall Street Analysts Take Note
Nasdaq 5d
Members of Congress Are Loading Up on Johnson & Johnson and UnitedHealth. Here's Why Retail Investors Should Pay Attention.

Key Points Rep. Lisa McClain (R-Mich.) has been a big buyer of Johnson & Johnson stock. Oklahoma Republican Sen. Markwayne Mullin has bought large chunks of U...

Members of Congress Are Loading Up on Johnson & Johnson and UnitedHealth. Here's Why Retail Investors Should Pay Attention.
TipRanks 6d
Guardant Health Price Target Raised to $200 on Accelerating Shield Adoption After Key UnitedHealth Coverage Win

Analyst Eve Burstein of Bernstein maintained a Buy rating on Guardant Health, boosting the price target to $200.00. Unlock powerful investing tools and data-dr...

The Motley Fool 6d
UnitedHealth Is Spending $3 Billion on AI and Getting $2 Back for Every $1. Why That Changes the Bull Case for This Blue Chip Stock.

Artificial intelligence (AI) has become more than a technology initiative at UnitedHealth Group (UNH +2.63%). It's increasingly becoming a business strategy. Th...

UnitedHealth Is Spending $3 Billion on AI and Getting $2 Back for Every $1. Why That Changes the Bull Case for This Blue Chip Stock.

People also own

Based on the portfolios of people who own UNH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.